Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates

Go back to Autolus Therapeutics Reports First Quarter 2026 Financial Results and Business Updates
(NASDAQ: AUTL) Delayed: 1.56 --0 (-0%)
Previous Close $1.56    52 Week High
Open $1.57    52 Week Low
Day High $1.64    P/E N/A 
Day Low $1.52    EPS
Volume 1,019,515